Precision Biosciences Inc

Research Precision Biosciences Inc (DTIL) on Bullrun: market cap USD 204.35M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerDTIL
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 204.35M
• Financial periodFY2025
• RevenueUSD 34.26M
• Revenue growth-50.1%
• Net income-USD 45.72M
• Free cash flow-USD 65.93M

Valuation Snapshot

latest market cap is USD 204.35M.

About Precision Biosciences Inc

Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States. The company offers ARCUS, a genome editing platform for DNA genome insertion, removal, and repair.

Frequently asked questions

What is Precision Biosciences Inc's market cap?

Precision Biosciences Inc's market capitalization is USD 204.35M.

What does Precision Biosciences Inc do?

Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States. The company offers ARCUS, a genome editing platform for DNA genome insertion, removal, and repair.